CRISPR is capable of more than we initially expected

our Twitter (X) feedView our Youtube channelView our Instagram feedView our Substack feedView our Spotify feed Nobel laureate Jennifer Doudna co-invented CRISPR in 2012. She's spent the years since watching it cure disease, spark debate, and even solve health and climate issues. Here’s what it’s doing today.

Doudna, Ph.D., Professor of Molecular and Cell Biology and Chemistry at the University of California, Berkeley, has devoted her scientific career to revealing the secret life of RNA.[…] Jennifer A. She never expected it would lead to this. What does 14 years of gene editing actually add up to?

Jennifer Doudna, the Nobel Prize-winning biochemist who co-invented CRISPR, walks through the full arc of the technology she helped create. She covers the FDA-approved, functionally curative — but $2 million — CRISPR therapy for sickle cell disease, efforts to reduce methane emissions from cattle and rice farming, and the ongoing ethical reckoning. Doudna also reflects on how CRISPR's early framework for responsible use compares to today's AI race, and where she thinks gene editing goes from here.

One video is just the beginningMembers go deeper — they get unlimited classes, early releases, zero ads, and our quarterly print issue. View our Twitter (X) feedView our Youtube channelView our Instagram feedView our Substack feedView our Spotify feed © Copyright 2007-2026 & BIG THINK, BIG THINK PLUS, SMARTER FASTER trademarks owned by Freethink Media, Inc.